EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum DNA methylome of the colorectal cancer serrated pathway enables non‐invasive detection

María Gallardo-Gómez, Lara Costas-Ríos, Carlos A Garcia-Prieto, Lara Álvarez-Rodríguez, Luis Bujanda, Maialen Barrero, Antoni Castells, Francesc Balaguer, Rodrigo Jover, Manel Esteller iD, Antoni Tardío Baiges, Joaquín González-Carreró Fojón und 2 weitere

Molecular Oncology · 2024

DOI: 10.1002/1878-0261.13573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2024. Verfasst von María Gallardo-Gómez und 13 weiteren Autor:innen. Beteiligte Einrichtung: CINBIO, Universidade de Vigo, Spain. Hauptthemen laut MEDLINE: Colorectal Neoplasms, DNA Methylation, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia, Ministerio de Educación, Cultura y Deporte.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical relevance of the colorectal cancer serrated pathway is evident, but the screening of serrated lesions remains challenging. We aimed to characterize the serum methylome of the serrated pathway and to evaluate circulating cell‐free DNA (cfDNA) methylomes as a potential source of biomarkers for the non‐invasive detection of serrated lesions. We collected serum samples from individuals with serrated adenocarcinoma (SAC), traditional serrated adenomas, sessile serrated lesions, hyperplastic polyps and individuals with no colorectal findings. First, we quantified cfDNA methylation with the MethylationEPIC array. Then, we compared the methylation profiles with tissue and serum datasets. Finally, we evaluated the utility of serum cfDNA methylation biomarkers. We identified a differential methylation profile able to distinguish high‐risk serrated lesions from no serrated neoplasia, showing concordance with tissue methylation from SAC and sessile serrated lesions. Serum methylation profiles are pathway‐specific, clearly separating serrated lesions from conventional adenomas. The combination of ninjurin 2 ( NINJ2 ) and glutamate‐rich 1 ( ERICH1 ) methylation discriminated high‐risk serrated lesions and SAC with 91.4% sensitivity (64.4% specificity), while zinc finger protein 718 ( ZNF718 ) methylation reported 100% sensitivity for the detection of SAC (96% specificity). This is the first study exploring the serum methylome of serrated lesions. Differential methylation of cfDNA can be used for the non‐invasive detection of colorectal serrated lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDNA MethylationBiomarkers, TumorHumansMaleFemaleMiddle AgedAgedAdenomaEpigenomeCell-Free Nucleic Acids

Stichwörter der Autor:innen

DNA methylationcirculating cell‐free DNAnon‐invasive biomarkersscreeningserrated colorectal cancerserrated lesions

Substanzen

Biomarkers, TumorCell-Free Nucleic Acids

Autor:innen und Institutionen

  • CINBIO, Universidade de Vigo, Spain.
  • Department of Biochemistry, Genetics and Immunology, Universidade de Vigo, Spain.
  • Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Spain.
  • Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain.
  • Life Sciences Department, Barcelona Supercomputing Center (BSC), Spain.
  • Department of Gastroenterology, Biodonostia Health Research Institute, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Universidad del País Vasco (UPV/EHU), San Sebastián, Spa…

ORCID-Profile: Manel Esteller, Loretta De Chiara

Förderung

  • Instituto de Salud Carlos III
  • Consellería de Cultura, Educación e Ordenación Universitaria, Xunta de Galicia
  • Ministerio de Educación, Cultura y Deporte
  • Fundación Científica Asociación Española Contra el Cáncer

Zitieren

APA

Gallardo-Gómez, M., Costas-Ríos, L., Garcia-Prieto, C. A., Álvarez-Rodríguez, L., Bujanda, L., Barrero, M., Castells, A., Balaguer, F., Jover, R., Esteller, M., Tardío Baiges, A., González-Carreró Fojón, J., Cubiella, J., & De Chiara, L. (2024). Serum DNA methylome of the colorectal cancer serrated pathway enables non‐invasive detection. Molecular Oncology. https://doi.org/10.1002/1878-0261.13573

Vancouver

Gallardo-Gómez M, Costas-Ríos L, Garcia-Prieto CA, Álvarez-Rodríguez L, Bujanda L, Barrero M, et al. Serum DNA methylome of the colorectal cancer serrated pathway enables non‐invasive detection. Molecular Oncology. 2024. doi:10.1002/1878-0261.13573

BibTeX
@article{GallardoGmez2024,
  author = {Gallardo-Gómez, María and Costas-Ríos, Lara and Garcia-Prieto, Carlos A and Álvarez-Rodríguez, Lara and Bujanda, Luis and Barrero, Maialen and Castells, Antoni and Balaguer, Francesc and Jover, Rodrigo and Esteller, Manel and Tardío Baiges, Antoni and González-Carreró Fojón, Joaquín and Cubiella, Joaquín and De Chiara, Loretta},
  title = {Serum DNA methylome of the colorectal cancer serrated pathway enables non‐invasive detection},
  journal = {Molecular Oncology},
  year = {2024},
  doi = {10.1002/1878-0261.13573}
}
Kostenlos starten →